[(2S)-1-henicosanoyloxy-3-tetradecanoyloxypropan-2-yl] docosanoate
C60H116O6 — CID 131808912
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(2S)-1-henicosanoyloxy-3-tetradecanoyloxypropan-2-yl] docosanoate
[(2S)-1-henicosanoyloxy-3-tetradecanoyloxypropan-2-yl] docosanoate (PubChem CID 131808912) has the molecular formula C60H116O6 and a molecular weight of 933.58 g/mol. Its IUPAC name is [(2S)-1-henicosanoyloxy-3-tetradecanoyloxypropan-2-yl] docosanoate.
Molecular Properties
| Compound Name | [(2S)-1-henicosanoyloxy-3-tetradecanoyloxypropan-2-yl] docosanoate |
|---|---|
| PubChem CID | 131808912 |
| Molecular Formula | C60H116O6 |
| Molecular Weight | 933.58 g/mol |
| Exact Mass | 932.88 |
| IUPAC Name | [(2S)-1-henicosanoyloxy-3-tetradecanoyloxypropan-2-yl] docosanoate |
| SMILES | CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCC |
| InChI | InChI=1S/C60H116O6/c1-4-7-10-13-16-19-22-24-26-28-30-32-34-36-39-42-45-48-51-54-60(63)66-57(55-64-58(61)52-49-46-43-40-37-21-18-15-12-9-6-3)56-65-59(62)53-50-47-44-41-38-35-33-31-29-27-25-23-20-17-14-11-8-5-2/h57H,4-56H2,1-3H3/t57-/m0/s1 |
| InChIKey | GKTPEIDFFUYNRK-SMWREMLRSA-N |
| XLogP | 19.94 |
| TPSA | 78.90 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 56 |
| Heavy Atoms | 66 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 933.58 |
| LogP ≤ 5 | 19.94 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 131808912 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.